Morgan Stanley analyst David Arcaro maintains Consolidated Edison (NYSE:ED) with a Underweight and raises the price target from $71 to $76.
Atara Biotherapeutics To Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel Commercialization Agreement With Pierre Fabre; Atara To Receive Additional $30M Upon European Commission Approval And Filing Of Tab-Cel
Atara to Receive Additional USD 30 Million Upon European Commission (EC) Approval and Filing of Tab-cel® Marketing Authorization Transfer to Pierre Fabre
Responses Submitted to European Medicines